Methods
The study was conducted at the University of Auckland,
New Zealand, between November 2001 and December 2002.
The study protocol and protocol-related documents were approved by the Auckland Ethics Committee and the New
Zealand Health Research Council’s Standing Committee on
Therapeutic Trials.